These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
244 related articles for article (PubMed ID: 37569430)
1. Use of Urinary Biomarkers in Discriminating Interstitial Cystitis/Bladder Pain Syndrome from Male Lower Urinary Tract Dysfunctions. Yu WR; Jiang YH; Jhang JF; Kuo HC Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569430 [TBL] [Abstract][Full Text] [Related]
2. Urine biomarker could be a useful tool for differential diagnosis of a lower urinary tract dysfunction. Yu WR; Jiang YH; Jhang JF; Kuo HC Tzu Chi Med J; 2024; 36(2):110-119. PubMed ID: 38645782 [TBL] [Abstract][Full Text] [Related]
3. Urinary Oxidative Stress Biomarker Levels Might Be Useful in Identifying Functional Bladder Disorders in Women with Frequency and Urgency Syndrome. Jiang YH; Jhang JF; Kuo HC J Clin Med; 2023 Mar; 12(6):. PubMed ID: 36983336 [TBL] [Abstract][Full Text] [Related]
4. Usefulness of Urinary Biomarkers for Assessing Bladder Condition and Histopathology in Patients with Interstitial Cystitis/Bladder Pain Syndrome. Jiang YH; Jhang JF; Hsu YH; Kuo HC Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233356 [TBL] [Abstract][Full Text] [Related]
5. Clinical presentation, videourodynamic characteristics, and treatment outcome in men with interstitial cystitis-like lower urinary tract symptoms. Yu WR; Chang WC; Kuo HC Int Urol Nephrol; 2022 Sep; 54(9):2157-2165. PubMed ID: 35804206 [TBL] [Abstract][Full Text] [Related]
6. Can We Use Urinary Cytokine/Chemokine Analysis in Discriminating Ulcer-Type Interstitial Cystitis/Bladder Pain Syndrome? Jiang YH; Jhang JF; Kuo HC Diagnostics (Basel); 2022 Apr; 12(5):. PubMed ID: 35626252 [TBL] [Abstract][Full Text] [Related]
7. Videourodynamic characteristics of interstitial cystitis/bladder pain syndrome-The role of bladder outlet dysfunction in the pathophysiology. Kuo YC; Kuo HC Neurourol Urodyn; 2018 Aug; 37(6):1971-1977. PubMed ID: 29504632 [TBL] [Abstract][Full Text] [Related]
8. Urine Oxidative Stress Biomarkers as Novel Biomarkers in Interstitial Cystitis/Bladder Pain Syndrome. Jiang YH; Jhang JF; Ho HC; Chiou DY; Kuo HC Biomedicines; 2022 Jul; 10(7):. PubMed ID: 35885006 [TBL] [Abstract][Full Text] [Related]
9. Discriminating Different Bladder and Bladder Outlet Dysfunctions by Urinary Biomarkers in Women with Frequency-Urgency Syndrome. Jhang JF; Jiang YH; Kuo HC Biomedicines; 2023 Feb; 11(3):. PubMed ID: 36979652 [TBL] [Abstract][Full Text] [Related]
10. Role of Bladder Dysfunction in Men with Lower Urinary Tract Symptoms Refractory to Alpha-blocker Therapy: A Video-urodynamic Analysis. Jiang YH; Liao CH; Kuo HC Low Urin Tract Symptoms; 2018 Jan; 10(1):32-37. PubMed ID: 27366877 [TBL] [Abstract][Full Text] [Related]
11. Urine cytokines as biomarkers for diagnosing interstitial cystitis/bladder pain syndrome and mapping its clinical characteristics. Jiang YH; Jhang JF; Hsu YH; Ho HC; Wu YH; Kuo HC Am J Physiol Renal Physiol; 2020 Jun; 318(6):F1391-F1399. PubMed ID: 32281420 [TBL] [Abstract][Full Text] [Related]
12. Using Urine Biomarkers to Differentiate Bladder Dysfunctions in Women with Sensory Bladder Disorders. Chen YC; Jiang YH; Jhang JF; Kuo HC Int J Mol Sci; 2024 Aug; 25(17):. PubMed ID: 39273307 [TBL] [Abstract][Full Text] [Related]
13. Use of Urinary Cytokine and Chemokine Levels for Identifying Bladder Conditions and Predicting Treatment Outcomes in Patients with Interstitial Cystitis/Bladder Pain Syndrome. Yu WR; Jiang YH; Jhang JF; Kuo HC Biomedicines; 2022 May; 10(5):. PubMed ID: 35625885 [TBL] [Abstract][Full Text] [Related]
14. Myofascial Frequency Syndrome: A novel syndrome of bothersome lower urinary tract symptoms associated with myofascial pelvic floor dysfunction. Ackerman AL; Jackson NJ; Caron AT; Kaufman MR; Routh JC; Lowder JL medRxiv; 2023 Apr; ():. PubMed ID: 37131628 [TBL] [Abstract][Full Text] [Related]
15. Role of videourodynamic study in precision diagnosis and treatment for lower urinary tract dysfunction. Jiang YH; Chen SF; Kuo HC Tzu Chi Med J; 2020; 32(2):121-130. PubMed ID: 32269943 [TBL] [Abstract][Full Text] [Related]
16. Combination of urinary biomarkers and machine-learning models provided a higher predictive accuracy to predict long-term treatment outcomes of patients with interstitial cystitis/bladder pain syndrome. Jhang JF; Yu WR; Huang WT; Kuo HC World J Urol; 2024 Mar; 42(1):173. PubMed ID: 38507059 [TBL] [Abstract][Full Text] [Related]
17. Alteration of Urothelial Inflammation, Apoptosis, and Junction Protein in Patients with Various Bladder Conditions and Storage Bladder Symptoms Suggest Common Pathway Involved in Underlying Pathophysiology. Liu HT; Jiang YH; Kuo HC Low Urin Tract Symptoms; 2015 May; 7(2):102-7. PubMed ID: 26663690 [TBL] [Abstract][Full Text] [Related]
18. Urinary nerve growth factor level is increased in patients with interstitial cystitis/bladder pain syndrome and decreased in responders to treatment. Liu HT; Tyagi P; Chancellor MB; Kuo HC BJU Int; 2009 Nov; 104(10):1476-81. PubMed ID: 19522864 [TBL] [Abstract][Full Text] [Related]
19. Videourodynamic findings of lower urinary tract dysfunctions in men with persistent storage lower urinary tract symptoms after medical treatment. Jiang YH; Wang CC; Kuo HC PLoS One; 2018; 13(2):e0190704. PubMed ID: 29462145 [TBL] [Abstract][Full Text] [Related]
20. Urine biomarkers in ESSIC type 2 interstitial cystitis/bladder pain syndrome and overactive bladder with developing a novel diagnostic algorithm. Jiang YH; Jhang JF; Hsu YH; Ho HC; Wu YH; Kuo HC Sci Rep; 2021 Jan; 11(1):914. PubMed ID: 33441752 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]